Sales of periodontal gel in the United States are expected to rise at a moderate CAGR of 3.1% through 2034. The demand outlook is projected to increase from USD 179.9 million in 2024 to USD 241.4 million by 2034. The industry was valued at USD 174.2 million in 2023.
Key Attributes
| Industry Valuation in 2023 | USD 174.2 million |
|---|---|
| Sales Outlook in 2024 | USD 179.9 million |
| Projected Demand Outlook for 2034 | USD 241.4 million |
| Value CAGR (2024 to 2034) | 3.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Non-surgical periodontal therapy methods, such as periodontal gels, are popular for various reasons, including their lack of invasiveness. Many people prefer non-surgical treatments because they are less painful and pose fewer risks. Non-surgical treatments are also available to help maintain and improve dental health over time, providing players with a lucrative opportunity to expand their offerings in the industry.
Furthermore, as technology and product formulations have advanced, non-surgical periodontal gels have become more effective in treating and managing periodontal disorders. Overall, the demand for non-surgical periodontal therapies reflects a shift toward a more patient-centered and holistic approach to periodontal care, which is fueling the popularity of periodontal gels.
The United States periodontal gel sales recorded a historic CAGR of 2.4% in the last five years from 2019 to 2023. The periodontal gel demand in the United States has undergone significant transformations throughout its history, shaped by changing healthcare practices, technological advancements, and shifting consumer preferences. Periodontal treatments have traditionally relied on traditional scaling and root planing methods. The introduction of periodontal gels, which offer more targeted and efficient solutions for gum disease, has caused a paradigm shift in the industry.
Due to the rising prevalence of periodontal diseases and an aging population, sales of periodontal gel in the United States have historically experienced steady growth. The growing awareness of oral health issues, as well as the demand for minimally invasive treatments, have all contributed to the growth of market. Companies have invested in R&D to introduce novel formulations and delivery mechanisms that improve the efficacy of periodontal gels.
Looking ahead, the periodontal gel sales in the United States is expected to expand further. The aging population, combined with an increase in the prevalence of lifestyle-related risk factors, is expected to fuel demand for periodontal treatments. Biomaterials and nanotechnology advancements may lead to the development of more sophisticated and personalized gels, improving treatment outcomes even further.
Likewise, the integration of digital health technologies and telehealth services could be critical to the industry's future success. Remote monitoring and virtual consultations may become more common, providing patients with more convenient options and expanding the reach of periodontal care.
Challenges such as regulatory considerations, reimbursement policies, and the competitive landscape could impact the industry dynamics. Companies will need to navigate these complexities while capitalizing on opportunities presented by emerging technologies and changing healthcare paradigms.
Principal Consultant
Partnerships and collaborations with other leading companies are being explored to develop and commercialize new and innovative periodontal gels.
For example, on June 10, 2022, Oral-B and Straumann formed a new global partnership to promote the importance of prevention in periodontal and peri-implant health. The association will set a higher standard for high-quality scientific education for dentists while also assisting their patients in achieving better long-term outcomes.
This collaboration from the key player can assist with technological advancements and product developments, which further aid in the growth of demand for periodontal gel in the United States.
Similarly, this industry has projected lucrative opportunities in the coming years owing to the increased research and development into periodontal treatment devices.
As per data from ClinicalTrials.gov, at the moment, there are around 220 clinical studies related to periodontal diseases that are recruiting and enrolling patients through invitations.
Patients continue to lack access to primary healthcare facilities that can provide adequate treatment. Many countries' national capacity and resources (including trained professionals as well as financial and material resources) are still insufficient to ensure the availability and accessibility of high-quality fundamental health services for the entire population, particularly in underserved communities.
Some countries are making changes to their public services, including the health-care system. This is helping to restructure the methods for funding and delivering healthcare services.
Another restraining factor for the industry is the limited number of insured people in the country. As a result of the nation's large number of uninsured citizens, clinical visits for oral health may be limited or eliminated, reducing the market for periodontal gels.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Northeast United States marks a sluggish rise in demand for periodontal gel with a CAGR of 1.8% through 2034. The rising prevalence of periodontal (gum) diseases is a key factor driving the periodontal gel demand in the Northeast. Periodontal diseases, such as gingivitis and periodontitis, are common oral health problems characterized by gum inflammation and potential damage to tooth-supporting structures.
As the prevalence of periodontal disease grows, more individuals seek professional dental care, leading to the diagnosis and treatment of periodontal diseases. The demand for convenient and efficient treatment options, such as periodontal gels, is consequently on the rise.
Southwest United States witnessed an increase in demand for periodontal gel at a CAGR of 4.0% through 2034. The periodontal gel market in this region is anticipated to witness a change in momentum as a result of oral health awareness efforts. As more individuals become aware of the value of maintaining good dental health and the necessity of taking preventative steps against potential oral diseases, there may be a rise in demand for periodontal gels from those looking for items that will help them keep their gums healthy.
Public awareness marketing about periodontal gels and other dental care products is common. This can promote the use of these items by assisting individuals in realizing their advantages.
Growth Outlook by Active Ingredients
| Active Ingredients | Value CAGR |
|---|---|
| Anti-microbial Agents | 1.8% |
| Antibiotics | 2.9% |
| Anti-inflammatory Agents | 3.8% |
| Antiseptics | 5.2% |
| Others | 4.6% |
Anti-microbial agents within the active ingredient segment hold a revenue share of 37.7% in 2023, and the same trend is being followed over the forecasted period. Dental professionals prefer antimicrobial agents as active ingredients in periodontal gels due to their effectiveness in treating and managing periodontal diseases. Bacterial plaque buildup on teeth and gums is the primary cause of periodontal diseases. These bacteria are specifically targeted and combated by antimicrobial agents such as chlorhexidine, triclosan, or metronidazole. This targeted approach aids in bacterial load reduction and infection control at the source.
Growth Outlook by Key Application
| Application | Value CAGR |
|---|---|
| Periodontitis | 3.1% |
| Gingivitis | 1.7% |
| Oral Ulcers and Lesions | 4.1% |
| Orthodontics | 5.9% |
| Other | 5.1% |
The increasing prevalence of Gingivitis in the United States has been a primary driver of the demand for periodontal gels. Gingivitis is becoming more common for a variety of reasons. Poor oral hygiene practices, tobacco use, and unhealthy diet choices all play a significant role. Furthermore, the aging population is at a higher risk of gum disease due to natural wear and tear on oral tissues over time.
Growth Outlook by Key Distribution Channel
| Distribution Channel | Value CAGR |
|---|---|
| Institutional Sales | 3.8% |
| Retail Sales | 2.5% |
The retail sales segment dominates the end-user category, holding a 58.5% share in 2023. Retail outlets, including pharmacies, drugstores, and supermarkets, provide widespread accessibility to consumers. These locations are frequented by a broad demographic, making it convenient for individuals to purchase periodontal gels without the need for a prescription. Many periodontal gels are available over-the-counter (OTC), allowing consumers to buy them without consulting a healthcare professional. This accessibility promotes self-care and empowers consumers to address their oral health needs proactively.
Geographic expansions are a priority for leading periodontal gel companies as they work to create new product lines and expand their consumer base. An increase in research and development is helping manufacturers to achieve better options as per the needs of the patients.
Recent Development
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Analysis | USD million for Value |
| Key Regions Covered | Northeast; Midwest; Southeast; Southwest and West |
| Key States Covered | New York, New Jersey, Massachusetts, Minnesota, Wisconsin, North Carolina, South Carolina, Florida, Virginia, Louisiana, Oklahoma, Texas, Washington, California, and New Mexico |
| Key Segments Covered | Active Ingredients, Applications, Distribution Channel and Region |
|
Key Companies Profiled |
Ivoclar Vivadent; Straumann; 3M; Dentaid; Dentovations Inc. (Oxyfresh); DENTSPLY SIRONA; Himalaya Wellness; Sunstar Group; Septodont; Henry Schein; Perio Protect; Den-Mat Holdings, LLC; FREZYDERM S.A; Curaden AG |
| Report Coverage | Industry Forecast, Competition Intelligence, DROT Analysis, Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The industry is currently valued at around USD 174.2 million in 2023.
The industry is set to reach a valuation of around USD 241.4 million by 2034.
The anti-microbial agents segment, within the product segment, held a 37.7% share in 2023.
Demand for periodontal gel in the United States increased at a 2.4% CAGR from 2019 to 2023.
The United States estimate for 2024 is around USD 179.9 million.
The demand for periodontal gel in the Southeast United States witnessed a CAGR of 4.0% in 2023.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Market Demand (in Value or Size in USD Million) Analysis 2018 to 2023 and Forecast, 2024 to 2034 7. Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Active Ingredients 7.1. Anti-Microbial agents 7.2. Antibiotics 7.3. Anti-inflammatory Agents 7.4. Antiseptics 7.5. Others 8. Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application 8.1. Periodontitis 8.2. Gingivitis 8.3. Oral Ulcers and Lesions 8.4. Orthodontics 8.5. Others 9. Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel 9.1. Institutional Sales 9.1.1. Dental Hospitals 9.1.2. Dental Clinics 9.1.3. Group Dental Practices 9.2. Retail Sales 9.2.1. Retail Pharmacies 9.2.2. Drug Stores 9.2.3. Hypermarkets and Supermarkets 9.2.4. Online Sales 10. Market: Cross-Sectional Analysis – Active Ingredients Vs Distribution Channel 10.1. Anti-Microbial agents 10.2. Antibiotics 10.3. Anti-inflammatory Agents 10.4. Antiseptics 11. Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 11.1. Northeast 11.2. Midwest 11.3. Southeast 11.4. Southwest 11.5. West 12. Northeast Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13. Midwest Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14. Southeast Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15. Southwest Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16. West Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17. Market Structure Analysis 18. Competition Analysis 18.1. Ivoclar Vivadent 18.2. Straumann 18.3. 3M 18.4. Dentaid 18.5. Dentovations Inc. (Oxyfresh) 18.6. DENTSPLY SIRONA 18.7. Himalaya Wellness 18.8. Sunstar Group 18.9. Septodont 18.10. Henry Schein 18.11. Perio Protect 18.12. Den-Mat Holdings, LLC 18.13. FREZYDERM S.A 18.14. Curaden AG 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Periodontal Gel Industry Analysis in the United States
